Early and Limited Use of Tacrolimus to Avoid Rejection in an Alemtuzumab and Sirolimus Regimen for Kidney Transplantation: Clinical Results and Immune Monitoring
Stuart J. Knechtle(Duke University), Hans W. Sollinger(University of Wisconsin–Madison), Robert B. Colvin(Harvard University), Katarzyna Bourcier(Immune Tolerance Network), Ewa Jankowska−Gan(University of Wisconsin–Madison), Julio Pascual(Hospital Del Mar), W.J. Burlingham(University of Wisconsin–Madison), DD. Bloom(University of Wisconsin–Madison), José Torrealba(The University of Texas Southwestern Medical Center), Vicki Seyfert‐Margolis(University of Washington), Jean Kwun(Duke University)
Cited by 66
Related Papers
The Banff 97 working classification of renal allograft pathology
|Kidney International|1999|3.1k
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
|American Journal of Transplantation|2008|1.9k
Reactivity of a monoclonal antibody with human ovarian carcinoma.
|Journal of Clinical Investigation|1981|1.7k
International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology
|Kidney International|1993|1.5k
Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
|American Journal of Transplantation|2014|1.3k